Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ceftriaxone as Home Intravenous Therapy for Deep-Seated Staphylococcal Infections, a Randomized Non-Inferiority Trial

NCT04141787 is registered in ClinicalTrials.gov with Vancouver Island Health Authority as lead sponsor.

NCT NCT04141787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ceftriaxone as Home Intravenous Therapy for Deep-Seated Staphylococcal Infections, a Randomized Non-Inferiority Trial
Lead sponsor
Vancouver Island Health Authority
Phase
Phase 4
Overall status
Unknown status
Start date
July 11, 2019
Completion date
March 30, 2024
Enrollment
310 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abscess, cns infection, coagulase negative staphylococcal infection, diabetic foot infection, osteomyelitis, septic arthritis, staphylococcal infections, vertebral osteomyelitis